Introduction of Vinyl and Hydroxymethyl
Functionalities at C-4 of Glucose-Derived
Substrates: Synthesis of Spirocyclic, Bicyclic, and
Tricyclic Nucleosides
Joy Krishna Maity,† Ramprasad Ghosh,†
Michael G. B. Drew,‡ Basudeb Achari,† and
Sukhendu B. Mandal*,†
Department of Chemistry, Indian Institute of Chemical
Biology, 4, Raja S. C. Mullick Road, JadaVpur,
Kolkata 700 032, India, and Department of Chemistry,
UniVersity of Reading, Whiteknights, Reading RG6 6AD,
United Kingdom
FIGURE 1. An approach to produce spirocycles and spironucleosides.
ReceiVed February 4, 2008
of a carbocyclic ring (a bulky substituent) at C-4′ of furanose/
thiofuranose rings. This was expected to fix the glycosyl
torsional angle around the C-4′ bond, while the void space below
C-4′ would be sufficient to avoid nonbonded steric superimposi-
tion. In addition, the free radical-induced degradation of the
ribose ring of nucleosides by C-4′-H abstraction can be
precluded. Various other synthetic routes to C-2′-spiro,5 C-3′-
spiro,6 and C-4′-spironucleosides4 as conformationally restricted
or biased analogues have appeared in the literature. Some of
these nucleosides display anti-HIV and antivirus activity.7 We
have earlier reported8 on the synthesis of spironucleosides
having 4- and 7-membered spiro rings at C-4′ through nucleo-
philic substitution and intramolecular nitrone cycloaddition
reaction. The work encouraged us to take up the synthesis of
spirocycles based on five-membered heterocyclic rings from a
D-glucose-derived precursor carrying two hydroxymethyl groups
at C-4. One of these groups was planned to be utilized to
introduce a vinyl group via oxidation and Wittig reaction, and
thenconvertedtoahydroxyethylgroupbyhydroboration-oxidation
reaction. Subsequent intra/intermolecular cyclization through the
participation of oxygen, nitrogen, and sulfur nucleophiles (Figure
1) was expected to furnish the desired heterocyclic systems. In
the process, we also encountered newer 4,5-spirocyclic and
bicyclo[3.3.0]octane systems. The products could be elaborated
to interesting spirocyclic and bicyclic nucleosides in addition
to an unexpected 5,5,5-tricyclic conformationally locked nucleo-
side as discussed in the sequel.
Installing hydroxymethyl and hydroxyethyl substitutions at
C-4 through vinylation and hydroboration-oxidation reac-
tions of the C-4 bis-hydroxymethyl derivative of D-glucose
based substrate, and inserting heteroatoms thereafter permit-
ted formation of N-, O-, or S-heterocycles leading to [4,5]-
or [5,5]-spirocycles and a bicyclo[3.3.0]octane product. Some
of the spirocycles were converted to spironucleosides under
Vorbru¨ggen glycosidation reaction conditions. Similarly, the
bicyclic product was elaborated to the corresponding bicyclic
nucleoside as well as an unexpected tricyclic nucleoside.
Hydantocidin, a pseudonucleoside possessing a spirocyclic
ring at the anomeric center, was reported from a natural source.1
Its unusual structure and bioactivity inspired Miyasaka2 and
others3 to synthesize C-1′-spironucleosides as conformationally
restricted molecules. Subsequently, Paquette4 introduced the
concept of spirocyclic restriction in nucleosides through insertion
(4) (a) Dong, S.; Paquette, L. A. J. Org. Chem. 2005, 70, 1580–1596. (b)
Hortung, R.; Paquette, L. A. J. Org. Chem. 2005, 70,1597–1604. (c) Paquette,
L. A.; Dong, S. J. Org. Chem. 2005, 70, 5655–5664. (d) Paquette, L. A. Aust.
J. Chem. 2004, 57, 7–17, and references cited therein.
† Indian Institute of Chemical Biology.
(5) Ravindra Babu, B.; Keinicke, L.; Petersen, M.; Nielsen, C.; Wengel, J.
Org. Biomol. Chem. 2003, 1, 3514–3526.
‡ University of Reading.
(1) Haruama, H.; Takayama, T.; Kinoshita, T.; Kondo, M.; Nakajima, M.;
Haneishi, T. J. Chem. Soc., Perkin Trans. 1991, 1, 1637–1640.
(2) Kittaka, A.; Asakura, T.; Kuze, T.; Tanaka, H.; Yamada, N.; Nakamura,
K. T.; Miyasaka, T. J. Org. Chem. 1999, 64, 7081–7093, and references cited
therein.
(6) Nielsen, P.; Larsen, K.; Wengel, J. Acta Chem. Scand. 1996, 50, 1030–
1035.
(7) (a) De Castro, S.; Lobaton, E.; Perez-Perez, M.-J.; San-Felix, A.; Cordeiro,
A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J.; Camarasa, M.-J.;
Velazquez, S. J. Med. Chem. 2005, 48, 1158–1168. (b) Crich, D.; Hao, X. J.
Org. Chem. 1999, 64, 4016–4024.
(3) (a) Gasch, C.; Pradera, M. A.; Salameh, B. A. B.; Molina, J. L.; Fuentes,
J. Tetrahedron: Asymmetry 2001, 12, 1267–1277. (b) Gimisis, T.; Chatgilialoglu,
C. J. Org. Chem. 1996, 61, 1908–1909. (c) Chatgilialoglu, C.; Gimisis, T.; Spada,
G. P. Chem. Eur. J. 1999, 5, 2866–2876.
(8) (a) Roy, A.; Achari, B.; Mandal, S. B. Tetrahedron Lett. 2006, 47, 3875–
3879. (b) Tripathi, S.; Roy, B. G.; Drew, M. G. B.; Achari, B.; Mandal, S. B.
J. Org. Chem. 2007, 72, 7427–7430.
10.1021/jo8002826 CCC: $40.75
Published on Web 04/24/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 4305–4308 4305